Liver disease due to chronic HBV or HCV infection is becoming a leading cause of death
among persons with HIV infection. Both the risk of hepatocellular carcinoma and the risk of …

Human immunodeficiency virus/hepatitis C virus (HIV/HCV) co‐infection has emerged as a
leading cause of liver morbidity in the last two decades. Liver failure is also frequently a …

Background: Liver-related illness is increasingly recognized as a source of morbidity in HIV-
infected patients. Fatty infiltration of the liver is potentially an important consequence of HIV …

Increased cardiovascular risk has been linked to HIV infection and combination antiretroviral
therapy, but the impact of hepatitis C virus (HCV) status on indices of cardiovascular risk has …

Background Significance of steatosis in HIV‐HCV coinfection remains controversial. Aim To
compare the prevalence and predictors of hepatic steatosis between HIV‐HCV and HCV …

Liver transaminases should be closely monitored after the start of highly active antiretroviral
therapy, and if elevated, differential diagnoses including immune reconstitution syndrome …

The management of HIV/AIDS has undergone a revolution in recent years. Following the
introduction of highly active antiretroviral therapies (HAARTs) in 1996, there was a rapid and …

HIV coinfection is associated with faster progression of liver disease resulting from hepatitis
B virus (HBV) or hepatitis C virus (HCV) infection. Thus, liver complications have become a …

Background: Hepatic steatosis is a common feature in liver biopsies from patients with
chronic hepatitis C and is associated with fibrosis progression. Patients with HIV infection …

The evaluation of hepatic histology and treatment of hepatitis C virus (HCV)/HIV-coinfected
patients is rapidly changing. HCV has become an important cause of mortality in HIV …